Skip to main content
Caplight Logo









Lansion Biotechnology Co., Ltd.

Lansion Biotechnology Co., Ltd.

Private
NanjingHealthcare & Life Scienceshttps://www.lansionbiotech.com

Last Round

Series D

Sep 9, 2022

Total Funding Raised

$14.5M

Company Overview

Lansion Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sale of in-vitro diagnostic (IVD) reagents and devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingPOCTfluorescence immunoassayin-vitro diagnosticIVDdiagnostic reagentsmedical device manufacturerrapid diagnostic testclinical laboratory equipmentbedside testingimmunoassay analyzerrazor and bladedecentralized testingdiagnostic hardwareclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lansion Biotechnology Co., Ltd. Comparables

Compare Lansion Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Lansion Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shenzhen Readline Biotechnology Co., Ltd.
85%
Hipro Biotechnology
82%
Guangzhou Wondfo Biotech Co., Ltd.
81%

Lansion Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DSep 9, 2022
Series CDec 1, 2020

Key People

Founding team and executive leadership

Jeffery Chen

Co-founder, Chief Technology Officer,

Founding Team

Lansion Biotechnology Co., Ltd. Investors

Notable investors and investment history

Lansion Biotechnology Co., Ltd. investors
InvestorRounds
Huasheng CapitalSeries C
MPCSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2022

    $15M round completed.

  • Dec 1, 2020

    Raised Series C round with investors Huasheng Capital and MPC.

Lansion Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lansion Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lansion Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range56
Year Founded2016
Last FundingSep 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?